Diagnostic and Prognostic Impact of Osteopontin Expression in Endometrial Cancer

Citations

WEB OF SCIENCE

18
Citations

SCOPUS

18

초록

The role of osteopontin as a biomarker in endometrial cancer has not been conclusively established. We evaluated the expression and potential of osteopontin as a biomarker for endometrial cancer. Real-time polymerase chain reaction and immunohistochemistry revealed osteopontin overexpression in endometrial cancer. The plasma osteopontin level in endometrial cancer was significantly higher than in healthy controls (P < 0.001). In FIGO stage I endometrial cancer, osteopontin correctly identified 18 of 29 cases (62.1%) that were not detected by CA125. By Cox multivariate analysis, osteopontin positivity was an independent prognostic factor for disease-free survival (hazard ratio = 3.18, P = 0.035).

키워드

Osteopontin (OPN); endometrial cancer; diagnostic marker; prognostic marker; DIFFERENT HISTOLOGIC TYPES; PREOPERATIVE CA 125; SERUM CA-125 LEVELS; CLINICAL STAGE-I; NEOPLASTIC TRANSFORMATION; MICROARRAY ANALYSIS; UTERINE-CANCER; OVARIAN-CANCER; DNA-PLOIDY; CARCINOMA
제목
Diagnostic and Prognostic Impact of Osteopontin Expression in Endometrial Cancer
저자
Cho, HanByoul; Kang, Eun Suk; Kim, Young Tae; Kim, Jae-Hoon
DOI
10.1080/07357900802375738
발행일
2009-01
유형
Article
저널명
Cancer Investigation
권
27
호
3
페이지
313 ~ 323